Influenza vaccine offered comparable effectiveness in children across all severity levels of illness, a 5-year-long CDC study ...

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...

Influenza vaccine is effective for preventing severe influenza illness among children, according to a study published.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

To learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near future ...

Registration is open for faculty to attend the Westwood Lecture Series on Jan. 28. Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, will present ...

Last year, Moderna completed a Phase 1/2 clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan ...

The following is a summary of “Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study,” published in the January 2025 issue of Infectious Disease by ...